Abstract
Type 1 diabetes is associated with an increased incidence of adverse maternal, fetal and neonatal outcomes. Strict glucose regulation can reduce diabetes associated pregnancy risks. Real-time continuous glucose monitoring (RtCGM) provides a new and more comprehensive diabetes treatment. Studies in the general diabetic population have shown a positive effect of rtCGM on HbA1c compared to self-monitoring of blood glucose (SMBG) alone.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
